Metsera (MTSR): Accounting Value of Company

Public company logo of Metsera (MTSR)

The development of anti-obesity treatments is currently an extremely competitive and overheated niche where startups must contend with two global behemoths. To survive, Metsera Inc (MTSR) is actively recruiting leading biochemists, securing their loyalty through stock option programs. The market price action, which currently stands at 0.34, underscores the interest in developing new peptides and the company's high probability of being acquired by a major player.

MTSR Metsera Therapeutics Book Capitalization (02/01/2025 - 11/29/2025)

Metric breakdowns and analytics for Metsera (MTSR)

- price and consensus price forecast:
Market Chart Metsera Therapeutics|MTSR - Price Target Chart
- market capitalization data:
Market Value Metsera, Inc.|MTSR - Total Company Value
- book capitalization data:
Share Book Value Metsera|MTSR - Book Capitalization|Market Value to Book Value metsera.com|MTSR - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Metsera Inc|MTSR - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Metsera, Inc.|MTSR - Company Debts|Debt to Book Value Metsera, Inc.
Fundamental valuation:MTSR - Metsera Therapeutics
Flagship merchandise of Metsera, Inc.

For the startup Metsera Inc (MTSR), which focuses on developing obesity drugs with minimal ESG expenditures, this indicator serves as a measure of the real value of net assets. By analyzing the dynamics of total balance sheet capital, an investor can see the difference between total liabilities and assets in real-time, allowing for an objective assessment of the business's intrinsic value and preventing overpayment for the company.

Competitor analysis for Metsera Inc

ASND: Book Valuation of Business|Company Book Value Madrigal Pharmaceuticals MDGL|CORT (corcept.com) - Accounting Value of Company|Company Book Value Rhythm Pharmaceuticals, Inc. RYTM|Net Asset Value Akero Therapeutics, Inc.|MoonLake Pharma (MLTX) - Book Capitalization|Accounting Value of Company Crinetics Corp (CRNX)|Book Capitalization NAMS (NewAmsterdam Pharma)|soleno.life - Book Capitalization|Company Book Value Amicus Therapeutics, Inc. (FOLD)|ETNB: Accounting Value of Company|AGIO (Agios Pharmaceuticals Inc) - Company Book Value|Structure Corp (GPCR) - Company Net Assets|MDXG (MiMedx Group, Inc.) - Book Capitalization|Book Capitalization rezolutebio.com (RZLT)|Lexicon Pharmaceuticals, Inc. (LXRX) - Company Net Assets|Accounting Value of Company MBX (MBX Biosciences, Inc.)|Altimmune Corp - Company Book Value|Company Net Assets Aardvark Pharma AARD|SGMT (Sagimet Biosciences) - Book Capitalization|bioagelabs.com (BIOA) - Total Stockholders' Equity|BMEA - Company Net Assets|Quince Therapeutics, Inc. (QNCX) - Total Net Assets|GUTS (Fractyl) - Book Capitalization|Book Capitalization vTv Therapeutics Inc|Book Capitalization Agape ATP Corporation (ATPC)|Company Book Value PLUR (pluri-biotech.com)|SYBX: Company Book Value|Lipocine Inc - Total Stockholders' Equity|MTNB - Company Book Value|SPRB - Company Book Value|Galecto, Inc. - Book Capitalization|CTCX (carmellrx.com) - Book Valuation of Business|LUMO: Company Book Value|Book Valuation of Business ONVO|Company Book Value RDUS (Radius Health)